855 336 3051 REIMBURSEMENT

800 373 1607 US

412 507 6182 INTERNATIONAL


Career Opportunity: Clinical Sales Representative – Mid-West Region


If you’re looking for an exciting career change and the following sounds enticing to you: Employee-first environment Zero dull moments Saving lives Never-ending supply of new learning experiences then TandemLife is looking for you!! We have an immediate full time opportunity available for an experienced Clinical Sales Representative in the mid-west US.  This individual will

53rd Annual STS Meeting


We’re excited to be exhibiting once again at the 53rd STS Annual Meeting.  This year TandemLife will be featuring brand new products just cleared in the past six months. Stop by Booth #823 to learn how ProtekDuo, TandemLung, and VoyagerVest combine to add incredible value to your patients and practice. Click ‘STS Advanced Program’ too

Heart transplant recipient receives the world’s first 31 Fr ProtekDuo™ cannula in a life-saving TandemLung® case


TandemLife® reveals details of the first clinical use of their new 31 Fr ProtekDuo cannula in combination with the recently released TandemLung oxygenator We’re thrilled to announce the commercial launch and first human use of our newest ProtekDuo dual lumen cannula at Cedars Sinai Heart Institute in Los Angeles. The cardiothoracic transplant team said the

TandemLife Named as Finalist for Pittsburgh Technology Council’s Tech 50 Innovator of the Year Award


TandemLife announced today, August 18th, that the Pittsburgh Technology Council has named it a Tech 50 Awards Finalist for the Innovator of the Year: Life Sciences category. “We are honored to have earned a place among some of the best life sciences companies in our region as one of the Tech50 finalists,” said John Marous,

TandemLife Training Videos


The launch of several new products and our recent company rebranding has prompted our team to produce new, comprehensive training videos.  Once production is completed all of our new training videos will be posted to our website.  Until then, please use the below links to access our existing material and, as always, feel free to